PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
71.81
-0.88 (-1.21%)
Aug 27, 2026, 4:00 PM EDT - Market closed

PTC Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,050984.65779.71594279.83189.72
Short-Term Investments
1,179960.72373.75288.81130.87583.66
Cash & Short-Term Investments
2,2291,9451,153882.81410.71773.38
Cash Growth
11.46%68.66%30.66%114.95%-46.89%-29.93%
Receivables
239.04181.62158.55261.02155.61110.46
Inventory
91.3579.6523.1930.5821.8115.86
Prepaid Expenses
57.8858.5122.9341.62105.6654.68
Other Current Assets
-8.87.42.6--
Total Current Assets
2,6172,2741,3661,219693.79954.37
Property, Plant & Equipment
126.27135.42117.66178.99175.02130.01
Long-Term Investments
-----21
Goodwill
82.3482.3482.3482.3482.3482.34
Other Intangible Assets
402.93388.75118.79379.5705.89724.84
Other Long-Term Assets
21.5818.320.736.2548.5825.5
Total Assets
3,2502,8991,7051,8961,7061,938

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
40.4545.4917.276.0527.2723.03
Accrued Expenses
328.58314.64261.72366.26276.33251.83
Current Portion of Long-Term Debt
369.67569.63257.82194.3172.15208.83
Current Portion of Leases
17.9715.4813.361612.3710.27
Current Income Taxes Payable
-4.684.7-4.711.29
Current Unearned Revenue
1.192.045.510.81.35-
Other Current Liabilities
13.2216.4720.619.6712.0514.1
Total Current Liabilities
771.07968.43580.98603.1406.24509.35
Long-Term Debt
2,5432,0252,1091,9041,257956.59
Long-Term Leases
87.5396.5890.52114.81119.5493.67
Long-Term Deferred Tax Liabilities
---55.91102.83137.11
Other Long-Term Liabilities
14.513.722.2336.44166.64239.9
Total Liabilities
3,4163,1042,8032,7142,0531,937

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.080.080.080.080.070.07
Additional Paid-In Capital
2,7122,7482,5752,4662,3052,124
Retained Earnings
-2,884-2,964-3,647-3,284-2,657-2,098
Comprehensive Income & Other
6.0210.5-25.89-1.294.8-24.28
Shareholders' Equity
-165.36-205.31-1,098-818.56-347.091.44
Total Liabilities & Equity
3,2502,8991,7051,8961,7061,938

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3,0182,7072,4712,2291,4621,269
Net Cash (Debt)
-788.82-761.69-1,318-1,346-1,051-495.99
Net Cash Growth
------
Net Cash Per Share
-9.66-8.63-17.15-17.99-14.65-7.04
Filing Date Shares Outstanding
83.4682.7778.8776.6173.8271.36
Total Common Shares Outstanding
83.3381.4777.775.7173.170.83
Working Capital
1,8461,306784.55615.53287.55445.02
Book Value Per Share
-1.98-2.52-14.13-10.81-4.750.02
Tangible Book Value
-650.63-676.41-1,299-1,280-1,135-805.74
Tangible Book Value Per Share
-7.81-8.30-16.72-16.91-15.53-11.38
Machinery
-64.459.7684.1966.6450.8
Construction In Progress
-2.83.0324.0114.359.02
Leasehold Improvements
-35.1631.5330.1728.9719.94
SEC Filings: 10-K · 10-Q